Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X)

In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)

(2011) Daniel F. Pauly et al.   AMERICAN HEART JOURNAL

Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors?: Position Paper from the Working Group on Coronary Pathophysiology and Microcirculation of the European Society of Cardiology

(2011) V. Vaccarino et al.   CARDIOVASCULAR RESEARCH

Ranolazine Improves Angina in Women With Evidence of Myocardial Ischemia But No Obstructive Coronary Artery Disease

(2011) Puja K. Mehta et al.   JACC-Cardiovascular Imaging

Exercise-Induced Spastic Coronary Artery Occlusion at the Site of a Moderate Stenosis

(2010) Ali Yilmaz et al.   CIRCULATION

Long-Term Administration of Endothelin Receptor Antagonist Improves Coronary Endothelial Function in Patients With Early Atherosclerosis

(2010) Martin Reriani et al.   CIRCULATION

Definitions and incidence of cardiac syndrome X: review and analysis of clinical data

(2010) I. A. C. Vermeltfoort et al.   Clinical Research in Cardiology

Low Diagnostic Yield of Elective Coronary Angiography

(2010) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combination of Variant and Microvascular Angina

(2009) Fabio Infusino et al.   CLINICAL CARDIOLOGY

A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study

(2009) T. F. Luscher et al.   EUROPEAN HEART JOURNAL

Coronary Artery Spasm as a Frequent Cause of Acute Coronary Syndrome

(2008) Peter Ong et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Fluvastatin, on Coronary Spasm After Withdrawal of Calcium-Channel Blockers

(2008) Hirofumi Yasue et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY